Australia's Rhythm Biosciences jumps after market entry into UK

Rhythm Biosciences

24/05/2023 02:14

** Shares of Rhythm Biosciences Ltd  RHY.AX  jump as much as
13.3% to A$0.51; on track for best day since May 17, if gains
hold 
    ** The medical diagnostics company says it has entered into
a strategic partnership with Link Medical Solutions that will
provide Rhythm with a market entry into the UK
    ** Says it will make its UK entry with ColoSTAT following
the test-kit's approval of the UKCA mark certification
    ** The ColoSTAT Test-Kit is Rhythm's blood test for the
detection of colorectal cancer
    ** Stock up 22.8% this year, as of last close

 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))